Class information for:
Level 1: ATRIAL FIBRILLATION//WARFARIN//CITY HOSP

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
215 3861 35.0 84%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
213 20130 ATRIAL FIBRILLATION//PULMONARY VEIN ISOLATION//CATHETER ABLATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 ATRIAL FIBRILLATION Author keyword 272 13% 49% 1906
2 WARFARIN Author keyword 86 15% 14% 531
3 CITY HOSP Address 74 22% 8% 293
4 DABIGATRAN Author keyword 51 25% 5% 174
5 ANTICOAGULATION Author keyword 50 11% 11% 412
6 STROKE PREVENTION Author keyword 49 27% 4% 158
7 ORAL ANTICOAGULATION Author keyword 45 32% 3% 118
8 AALBORG THROMBOSIS UNIT Address 45 69% 1% 38
9 APIXABAN Author keyword 42 30% 3% 117
10 CHADS2 Author keyword 32 69% 1% 27

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 ATRIAL FIBRILLATION 272 13% 49% 1906 Search ATRIAL+FIBRILLATION Search ATRIAL+FIBRILLATION
2 WARFARIN 86 15% 14% 531 Search WARFARIN Search WARFARIN
3 DABIGATRAN 51 25% 5% 174 Search DABIGATRAN Search DABIGATRAN
4 ANTICOAGULATION 50 11% 11% 412 Search ANTICOAGULATION Search ANTICOAGULATION
5 STROKE PREVENTION 49 27% 4% 158 Search STROKE+PREVENTION Search STROKE+PREVENTION
6 ORAL ANTICOAGULATION 45 32% 3% 118 Search ORAL+ANTICOAGULATION Search ORAL+ANTICOAGULATION
7 APIXABAN 42 30% 3% 117 Search APIXABAN Search APIXABAN
8 CHADS2 32 69% 1% 27 Search CHADS2 Search CHADS2
9 RIVAROXABAN 30 20% 3% 134 Search RIVAROXABAN Search RIVAROXABAN
10 HAS BLED 30 100% 0% 12 Search HAS+BLED Search HAS+BLED

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 PREDICTING STROKE 417 68% 9% 365
2 STROKE PREVENTION 383 43% 18% 687
3 ANTITHROMBOTIC THERAPY 344 38% 19% 717
4 WARFARIN 227 19% 28% 1084
5 CLINICAL CLASSIFICATION SCHEMES 163 76% 3% 114
6 RE LY TRIAL 155 58% 5% 177
7 WARFARIN USE 143 73% 3% 111
8 DABIGATRAN 122 36% 7% 273
9 EURO HEART SURVEY 120 54% 4% 153
10 ORAL ANTICOAGULATION 107 30% 8% 299

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation 2007 1096 41 80%
Stroke Prevention in Atrial Fibrillation A Systematic Review 2015 5 109 89%
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review 2010 198 64 95%
Antithrombotic therapy in atrial fibrillation 2008 362 233 48%
Screening to identify unknown atrial fibrillation A systematic review 2013 34 43 88%
Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes 2015 2 14 100%
Why do patients with atrial fibrillation not receive warfarin? 2000 330 42 79%
Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century 2013 49 139 56%
Electrocardiographic Monitoring for Detecting Atrial Fibrillation After Ischemic Stroke or Transient Ischemic Attack Systematic Review and Meta-Analysis 2015 2 68 87%
Cryptogenic stroke: Is silent atrial fibrillation the culprit? 2015 2 48 85%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CITY HOSP 74 22% 7.6% 293
2 AALBORG THROMBOSIS UNIT 45 69% 1.0% 38
3 AALBORG AF STUDY GRP 13 61% 0.4% 14
4 GEELONG CARDIOL 9 83% 0.1% 5
5 BIOSTAT HLTH SERV 7 38% 0.4% 14
6 EORP 6 80% 0.1% 4
7 ATRIAL FIBRILLAT STUDY GRP 6 71% 0.1% 5
8 MED ORADEA 6 100% 0.1% 4
9 UPPSALA CLIN 6 11% 1.3% 49
10 HOSP UNIV MORALES MESEGUER 5 34% 0.3% 11

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000220207 RIVAROXABAN//DABIGATRAN//APIXABAN
2 0.0000176018 DRONEDARONE//CARDIOVERSION//IBUTILIDE
3 0.0000174601 LEFT ATRIAL APPENDAGE//SPONTANEOUS ECHO CONTRAST//LEFT ATRIAL APPENDAGE FUNCTION
4 0.0000157580 INTERNATIONAL SENSITIVITY INDEX//PROTHROMBIN TIME//INTERNATIONAL NORMALIZED RATIO
5 0.0000130022 LONE AF//4Q25//LONE ATRIAL FIBRILLATION
6 0.0000087986 PROTHROMBIN COMPLEX CONCENTRATE//PROTHROMBIN COMPLEX CONCENTRATES//ANTICOAGULATION REVERSAL
7 0.0000085751 PRIMARY VENTRICULAR FIBRILLATION//CARDIOMETABOL PHYSIOPATHOL PHARMACOL//GISSI COORDINATING
8 0.0000078691 ATRIAL REMODELING//ELECTRICAL REMODELING//SUPRAVENTR ARRHYTHMIA
9 0.0000069367 CYP2C9//VKORC1//WARFARIN
10 0.0000063241 ANCROD//DEFIBRINOGENATION//STROKE IN PROGRESSION